(Q86893505)
Statements
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study (English)
Amparo Ruiz
Manuel Ruiz Borrego
Agustí Barnadas
Sonia González
Lourdes Calvo
Mireia Margelí Vila
Antonio Antón
Alvaro Rodríguez-Lescure
Miguel Angel Seguí-Palmer
Montserrat Muñoz-Mateu
Joan Dorca Ribugent
José Manuel López-Vega
Carlos Jara
Enrique Espinosa
César Mendiola Fernández
Raquel Andrés
Nuria Ribelles
Arrate Plazaola
Pedro Sánchez-Rovira
Javier Salvador Bofill
Carmen Crespo
Francisco J Carabantes
Sonia Servitja
José Ignacio Chacón
César A Rodríguez
Blanca Hernando
Isabel Álvarez